Therefore, BDNF is a biomarker of cognitive function, and therapeutic approaches targeting the ERK-CREB-BDNF pathway can be an effective strategy in developing potential therapeutics for cognitive impairment [16,17]. Here, CREB1 is linked to Cognitive impairment.